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OBJECTIVE— The prevalence of abdominal obesity exceeds that of general obesity. We
sought to determine the prevalence of abdominal subcutaneous and visceral obesity and to
characterize the different patterns of fat distribution in a community-based sample.
RESEARCH DESIGN AND METHODS— Participants from the Framingham Heart
Study (n  3,348, 48% women, mean age 52 years) underwent multidetector computed
tomography; subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) volumes
were assessed. Sex-specific high SAT and VAT definitions were based on 90th percentile cut
points from a healthy referent sample. Metabolic risk factors were examined in subgroups
with elevated SAT and VAT.
RESULTS— The prevalence of high SAT was 30% (women) and 31% (men) and that for
high VAT was 44% (women) and 42% (men). Overall, 27.8% of the sample was discordant
for high SAT and high VAT: 19.9% had SAT less than but VAT equal to or greater than the
90th percentile, and 7.9% had SAT greater than but VAT less than the 90th percentile. The
prevalence of metabolic syndrome was higher among women and men with SAT less than the
90th percentile and high VAT than in those with high SAT but VAT less than the 90th
percentile, despite lower BMI and waist circumference. Findings were similar for hyperten-
sion, elevated triglycerides, and low HDL cholesterol.
CONCLUSIONS— Nearly one-third of our sample has abdominal subcutaneous obesity,
and 40% have visceral obesity. Clinical measures of BMI and waist circumference may mis-
classify individuals in terms of VAT and metabolic risk.
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O besity is associated with an in-creased risk of multiple cardiom-etabolic risk factors. The prevalence
of obesity in the U.S. has increased over
the last two decades, with one-third of
adults having a BMI30 kg/m2 (1). How-
ever, obesity is a heterogeneous condition
with individual differences in the pattern
of adipose tissue deposition. Accumula-
tion of abdominal fat, particularly in the
visceral compartment, may confer the
majority of obesity-associated health
risks (2).
The prevalence of abdominal obesity
(defined as waist circumference 88 cm
in women and 102 cm in men) has in-
creased over the last decade and now ex-
ceeds the prevalence of overall obesity,
with rates of 42.4% in men and 61.3% in
women (1,3). Notably, the largest relative
increase in the prevalence of abdominal
obesity has been among individuals with
BMI 30 kg/m2 (3). Although waist cir-
cumference is an easily obtainable index
of abdominal adiposity, it does not distin-
guish between the subcutaneous and vis-
ceral adipose tissue compartments. We
and others have previously reported that
visceral adipose tissue (VAT) has a stron-
ger association with metabolic risk factors
and metabolic syndrome than subcutane-
ous adipose tissue (SAT) (4–6). These
studies are limited, however, by the high
correlations between SAT and VAT that
make it difficult to distinguish between
the contribution of SAT compared with
that of VAT with regard to metabolic risk.
Thus, the objectives of the present
study were twofold. First, we sought to
define the prevalence of abdominal obe-
sity in terms of elevated volumes of VAT
and SAT, as measured by a volumetric
computed tomography (CT) method. To
do this, we developed cut points for ele-
vated SAT and VAT based on a healthy
referent sample. Second, we examined
the occurrence of different patterns of ad-
ipose tissue distribution and concomitant
metabolic risk factor profiles. We hypoth-
esized that metabolic risk factors would
be more likely to track with elevated lev-
els of VAT than with SAT.
RESEARCH DESIGN AND
METHODS— The study sample con-
sisted of women and men enrolled in the
community-based Framingham Heart
Study Offspring and Third Generation
cohorts who participated in a multidetec-
tor computed tomography (MDCT) sub-
study. As part of the MDCT substudy,
3,529 participants (2,111 Third Genera-
tion and 1,418 Offspring participants)
underwent MDCT scanning of the
chest and abdomen for assessment of cor-
onary and aortic calcium between June
2002 and April 2005. Of the total 3,529
subjects imaged, 3,371 had interpretable
CT measures and 3,348 had both SAT
and VAT measured, resulting in a total
sample size of 3,348 individuals for the
present investigation.
The study protocol was approved by
the institutional review boards of the Bos-
ton University Medical Center and Mas-
sachusetts General Hospital. All subjects
provided written informed consent.
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Additional details regarding the study
sample selection, abdominal adipose tis-
sue imaging and volumetric measure-
ments, risk factor assessment, and
statistical analysis can be found in the
supplemental methods (available in an
online appendix at http://dx.doi.org/10.
2337/dc08-1359).
RESULTS— Overall, 1,611 women
and 1,737 men were available for analy-
sis; study sample characteristics are
shown in Table 1. SAT and VAT percen-
tiles in women and men by age are shown
in supplemental Table A1.
Healthy referent group
The healthy referent sample was com-
posed of 471 women and 285 men. The
90th percentile cutoffs of SAT and VAT
for this healthy referent group were 3,735
and 1,359 cm3, respectively, in women
and 2,979 and 2,323 cm3 in men.
Prevalence of elevated SAT and VAT
The prevalence of subcutaneous abdomi-
nal obesity (high SAT) in the overall sam-
ple was 30% in women and 31% in men.
The prevalence of visceral obesity (high
VAT) was 44% in women and 42% in
men. The prevalence of high SAT and
high VAT by age-group is presented in
Fig. 1.
In a secondary analysis, the lean
healthy referent (further excluding indi-
viduals with BMI 25 kg/m2) 90th per-
centile cut points in this sample were
2,883 and 2,031 cm3 for SAT and 1,062
and 1,715 cm3 for VAT in women and
men, respectively. Applying these cut
points to the overall sample would result
in the prevalence of high SAT of 50% in
women and 66% in men and high VAT of
56% in women and 67% in men.
Prevalence of high SAT and high
VAT by BMI and waist
circumference categories
The prevalence of high SAT and VAT in-
creased with increasing BMI category
(Fig. 2A). Among obese individuals, 22%
of men and 10% of women did not have
high VAT. Similarly, among individuals
with a high waist circumference, 28% of
men and 27% of women did not have
high VAT (Fig. 2B). Conversely, 10% of
men and 11% of women who are of nor-
mal BMI had high VAT, and 22% of men
and 8% of women with a normal waist
circumference had high VAT.
Metabolic risk factor prevalence
among SAT and VAT subgroups
The prevalence of metabolic syndrome
was significantly different across the four
SAT/VAT groups (P  0.0001 across the
four groups) (Fig. 3); clinical characteris-
tics of these groups are shown in Table 2.
Overall, 49.3% of the sample had both
SAT and VAT 90th percentile, whereas
22.9% had both high SAT and VAT.
Nearly 28% of the sample was discordant
in terms of SAT and VAT: 7.9% had high
SAT and VAT 90th percentile, whereas
19.9% had SAT 90th percentile but
high VAT. The mean age was higher
among those with SAT 90th percentile
and high VAT compared with those with
high SAT and VAT90th percentile. The
prevalence of metabolic syndrome was
higher among those with SAT90th per-
centile and high VAT compared with the
group with high SAT and VAT 90th
percentile (Fig. 3); similar patterns were
noted for elevated triglycerides and low
HDL cholesterol. This pattern was not ex-
plained by a higher body weight or ab-
Table 1—Clinical characteristics of overall sample
Women Men
n 1,611 1,737
Age (years) 52.2  9.9 49.8  10.7
BMI (kg/m2) 27.1  5.8 28.4  4.5
Waist circumference (cm) 93  15 101  12
Low HDL cholesterol (%)* 26 33
Elevated triglycerides (%)† 27 44
Hypertension (%) 26.8 32.0
Impaired fasting glucose (%)‡ 19 40
Diabetes (%) 5.6 7.4
Metabolic syndrome (%) 28 38
CVD (%) 4.3 7.8
Hypertension treatment (%) 18.7 19.8
Lipid treatment (%) 10.7 17.7
Diabetes treatment (%) 3.3 3.9
SAT (cm3) 3,148  1,519 2,640  1,206
VAT (cm3) 1,365  832 2,243  1,023
Data are means  SD or %. *Low HDL defined as 40 mg/dl (men) and 50 (women). †Elevated
triglycerides defined as150 mg/dl or lipid treatment. ‡Defined as fasting plasma glucose 100–125 mg/dl
in the absence of diabetes treatment.
Figure 1—Prevalence of high SAT (A) and high VAT (B) by age-group in women (f) and men (). Error bars represent SE. For SAT, the linear
trends were not significant (P 0.76 for men and P 0.11 for women). For VAT, the linear trends were significant for both men (P 0.0001) and
women (P  0.0001).
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dominal girth in the group with SAT
90th percentile but with high VAT:
those with SAT 90th percentile and
high VAT had a lower BMI and smaller
waist circumference. Results for cardio-
vascular disease (CVD) prevalence by the
four SAT/VAT groups are presented in
Fig. 3.
CONCLUSIONS
Major findings
Volumetric measures of both SAT and
VAT revealed a prevalence of high SAT of
30% and a prevalence of high VAT of
just more than 40% as defined by 90th
percentile cut points in a healthy referent
sample. The prevalence of elevated VAT
rises with age, whereas elevated SAT de-
clines among elderly individuals. Nearly
one-quarter of obese individuals or indi-
viduals with a large waist do not have el-
evated VAT, whereas 10% of women and
20% of men with a normal waist circum-
ference have high VAT, suggesting that
misclassification exists within clinically
useful adiposity categories. Discordant
amounts of SAT and VAT exist in nearly
30% of our sample, and adverse meta-
bolic risk factor profiles are more likely to
track with those with elevated VAT com-
pared with elevated SAT. Last, among
these discordant obesity subgroups, BMI
and waist circumference were actually
lower among higher risk groups.
We secondarily evaluated a “lean
healthy referent” sample and found that
the prevalence of elevated VAT and SAT
was even higher than that for the sample
that included overweight individuals in
the healthy referent sample. Given that
the lean healthy referent sample excluded
overweight individuals, this result is not
surprising. However, the lean healthy ref-
erent sample consisted of 500 individ-
uals, and the robustness of these estimates
is not clear.
The prevalence of elevated SAT de-
clines with age, whereas elevated VAT
rises among older individuals. These find-
ings are consistent with the observation
that the aging process is associated with
loss of subcutaneous fat and gain of fat
accumulation in the visceral depot. De-
spite more visceral fat but less subcutane-
ous fat among older individuals, BMI
actually declines with age (7) primarily
because of loss of fat-free mass and fat
mass. Both BMI and waist circumference
are more strongly correlated with subcu-
taneous than with visceral fat (4). There-
fore, both anthropometric measures may
be less reliable in aging individuals, as
BMI and waist circumference may be
more dependent on the relative loss of
SAT over time. This is consistent with the
observation in the present article that al-
though individuals with high VAT and
SAT 90th percentile had more adverse
risk factor profiles, BMI and waist circum-
ference were actually lower compared
with those in individuals with high SAT
and VAT 90th percentile.
In the context of the current
literature
In our cohort, the prevalence of subcuta-
neous adiposity is 30%, which is con-
sistent with current estimates of the
prevalence of obesity (as defined by a BMI
of at least 30 kg/m2) of 32.2% in U.S.
adults (1). The prevalence of visceral obe-
sity in our sample (42% in men and 44%
in women) exceeds the prevalence of sub-
cutaneous adiposity. Of note, the preva-
lence of abdominal obesity in women
(defined by a waist circumference 88
cm) in National Health and Nutrition Ex-
amination Survey data is higher than the
prevalence of visceral obesity (defined by
VAT 90th percentile healthy referent
cut point) in our sample of women (61.3
vs. 44%). This difference was not ob-
served in men. However, clinical anthro-
pometrics are well-known to be poor for
estimating VAT, and, thus, it is not sur-
prising that there is a discrepancy be-
tween a prevalence based on waist
circumference and one based on more
precise CT measurements (8).
Clinical categories to classify BMI and
waist circumference are useful for pre-
dicting risk of adiposity-related disorders
in the majority of patients, but misclassi-
fication exists (9). Some individuals who
have normal BMI and normal waist cir-
cumference have an excessive amount of
visceral fat that is unrecognized and thus
have a significant cardiometabolic risk.
This phenotype of a metabolically obese
normal-weight individual was first de-
scribed in the 1980s by Ruderman et al.
(10) and was classified as an individual
with a nonobese BMI who showed evi-
dence of impaired insulin sensitivity with
a hyperinsulinemic-euglycemic clamp.
Conversely, the metabolically healthy
obese individual (11) represents individ-
uals with a high BMI who seem to be
protected from associated metabolic de-
Figure 2—Prevalence of high SAT or high VAT by BMI category in women (A) and men (B) and
by waist circumference category in women (C) andmen (D). Error bars represent SE.A and B:,
normal weight; o, overweight; f, obese. C and D:, normal waist circumference; f, high waist
circumference.
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rangements including insulin resistance.
These different phenotypes underscore
the importance of identifying and treating
cardiometabolic risk factors, irrespective
of BMI.
To further explore the existence of
different fat phenotypes in a community-
based setting, we looked at groups that
were discordant for SAT and VAT and
found that the group with low SAT but
high VAT had a greater prevalence of met-
abolic syndrome than the group with high
SAT but low VAT. The collinearity of SAT
and VAT (correlations ranging between
0.58 in men and 0.71 in women) (4)
makes it difficult to assess the differential
contribution of SAT compared with VAT
with regard to metabolic risk. However,
the examination of risk factors among dis-
cordant categories of high SAT and high
VAT in our study suggests that a more
adverse risk factor profile tracks with high
VAT than with high SAT. This suggestion
is supported by the extensive literature
suggesting a uniquely important contri-
bution of visceral fat to metabolic risk and
a correlation of excess VAT with meta-
bolic risk independent of SAT (12–16).
Nonetheless, it is important to note that
the mean BMI and waist circumference
were actually lower among participants
with elevated VAT and normal SAT, high-
lighting the potential misclassification in
clinical anthropometrics.
Compared with the high SAT and
high VAT group, the low SAT and high
VAT group had a higher prevalence of
hypertriglyceridemia. These findings
may be consistent with a pattern similar
to the metabolic abnormalities present
in partial lipodystrophy. The lack of
sufficient adipocytes and the limited ca-
pacity to store fat in nonlipodystrophic
adipose tissue may result in ectopic fat
storage around other tissues and organs
such as the heart, the liver, skeletal
muscles, blood vessels, and kidneys
(17,18). This ectopic fat storage may
lead to organ dysfunction (19).
Figure 3—Prevalence of metabolic risk factors (MetS) and CVD by SAT/VAT concordant and
discordant categories in women (A) and men (B). Age-adjusted P  0.0001 across all four
categories for each risk factor except cardiovascular disease (P 0.01 for men and P 0.05 for
women). *P  0.01 for the low SAT/high VAT and high SAT/low VAT comparisons. Error bars
represent upper one-sided 97.5% CIs. HTN, hypertension; IFG, impaired fasting glucose; TG,
triglyceride.z, low SAT and VAT;, high SAT and low VAT;o, low SAT and high VAT;f, high
SAT and VAT.
Table 2—Distribution of risk factors and clinical characteristics by SAT/VAT categories*
Risk factor
Low SAT/low
VAT
High SAT/low
VAT
Low SAT/high
VAT
High SAT/high
VAT
P value comparing
discordant SAT and VAT
P value across
groups
n 1,650 266 666 766
Men
Age (years) 49 47 58 54 0.0001 0.0001
BMI (kg/m2) 25.6 30.2 28.5 34.0 0.0001 0.0001
Waist circumference (cm) 93 107 101 116 0.0001 0.0001
SAT (cm3) 1,861 3,753 2,317 4,190 0.0001 0.0001
VAT (cm3) 1,532 1,898 2,959 3,315 0.0001 0.0001
Women
Age (years) 51 51 61 56 0.0001 0.0001
BMI (kg/m2) 23.2 29.5 27.1 34.4 0.0001 0.0001
Waist circumference (cm) 83 99 95 112 0.0002 0.0001
SAT (cm3) 2,088 4,530 2,955 5,157 0.0001 0.0001
VAT (cm3) 773 1,103 1,831 2,283 0.0001 0.0001
SAT and VAT categories are defined as high if90th percentile cut points in healthy referent sample: SAT, men 2,979 cm3; women 3,735 cm3; VAT, men
2,323 cm3; women  1,359 cm3.
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Implications: limitations of BMI and
waist circumference, particularly
among older individuals
Clinical categories of BMI and waist cir-
cumference may be useful to estimate
overall metabolic risk in the general pop-
ulation, but there may be individuals who
develop cardiometabolic complications
related to adiposity without a BMI or
waist circumference in the high-risk
range. In particular, we observed that
among individuals discordant for high
SAT and VAT, BMI and waist circumfer-
ence were actually lower among those
with high VAT and low SAT, despite hav-
ing a higher prevalence of metabolic risk
factors. Therefore, the reliance on BMI
and waist circumference in the aging pop-
ulation may misclassify metabolic risk.
Strengths and limitations
Strengths of our study include the use of a
large community-based sample with de-
tailed risk factor assessment. We used a
highly reproducible CT assessment of
SAT and VAT volumes, which accounts
for heterogeneity of fat distribution
throughout the abdomen. Our sample
size was large enough to explore differ-
ences within obesity subgroups. Our
study is a population-based epidemio-
logic study without ascertainment for
obesity-related conditions, which in-
creases the generalizability of our find-
ings. Limitations include the use of cross-
sectional data, as causality cannot be
inferred. Because the Framingham Off-
spring study is primarily a Caucasian
sample, generalizability to other races or
ethnic groups is uncertain.
In summary, nearly one-third of our
sample has abdominal subcutaneous obe-
sity and more than 40% have visceral obe-
sity. Different patterns of adipose tissue
distribution have different metabolic cor-
relates. Clinical measures of BMI and
waist circumference may misclassify indi-
viduals in terms of metabolic risk.
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